A Case of Naturally Acquired Inhalation Anthrax: Clinical Care and Analyses of Anti-Protective Antigen Immunoglobulin G and Lethal Factor
Clinical Infectious Diseases2007Vol. 44(7), pp. 968–971
Citations Over TimeTop 10% of 2007 papers
John J. Walsh, Nicki Pesik, Conrad P. Quinn, Verónica Urdaneta, Clare A. Dykewicz, Anne E. Boyer, Jeannette Guarner, Patricia P. Wilkins, K. J. Norville, John R. Barr, Sanaa Zaki, Jean B. Patel, Sarah Reagan, James L. Pirkle, Tracee A. Treadwell, Nancy Messonnier, Lisa D. Rotz, Richard F. Meyer, David S. Stephens
Abstract
This report describes the first case of naturally acquired inhalation anthrax in the United States since 1976. The patient's clinical course included adjunctive treatment with human anthrax immunoglobulin. Clinical correlation of serologic assays for the lethal factor component of lethal toxin and anti-protective antigen immunoglobulin G are also presented.
Related Papers
- → The early humoral immune response toBacillus anthracistoxins in patients infected with cutaneous anthrax(2011)29 cited
- → Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes(2020)13 cited
- → Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R(2016)14 cited
- → Study of Immunization against Anthrax with the Purified Recombinant Protective Antigen of Bacillus anthracis(1998)46 cited
- Progress in research on neutralizing antibody against Bacillus anthracis(2010)